Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | X019102 | OT / RL |
| VARCEL | VARICELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | Y013066 | OT / RL |
No adverse event; improper storage of product in use; This spontaneous report was received from a nurse and refers to an 1-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 25-Mar-2025, the patient was vaccinated with an improper stored doses of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (valid lot #X019102, expiration date reported and confirmed as 16-Jul-2025), dose number 1, administered by subcutaneous route in right thigh as prophylaxis and with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (valid lot #Y013066, expiration date reported and confirmed as 29-Jul-2026), dose number 1, administered by subcutaneous route in right thigh as prophylaxis. The suspect vaccines were reconstituted with a sterile diluent (Hollister-Stier STERILE DILUENT) (lot # and expiration date were not reported) as prophylaxis. Temperature excursion occurred a result of a reading from a Digital Data Logger and both vaccines were given prior to known excursion. No adverse events reported. Lot # is being requested and will be submitted if received The is one of several reports received from the same reporter.
sterile diluent; sterile diluent